Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 17,198 $ 13,724
Investments 131,864 7,182
Restricted cash 285 192
Prepaid expenses and other current assets 3,629 2,448
Total current assets 152,976 23,546
Restricted cash 385 478
Property and equipment, net 385 973
Operating lease right-of-use assets 2,133 3,063
Other assets 0 212
Total assets 155,879 28,272
Current liabilities:    
Notes payable 0 301
Accounts payable 4,786 3,179
Accrued expenses 5,426 11,030
Derivative liability 0 39
Operating lease liabilities, current 1,606 1,437
Loan payable 0 15,908
Total current liabilities 11,818 31,894
Other long-term liabilities 0 44
Operating lease liabilities, noncurrent 1,633 3,239
Total liabilities 13,451 35,177
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at December 31, 2024 and 2023 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized, 12,179,482 and 4,423,683 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 1 0
Additional paid-in capital 619,285 429,780
Accumulated deficit (476,893) (436,684)
Accumulated other comprehensive loss 35 (1)
Total stockholders’ equity 142,428 (6,905)
Total liabilities and stockholders’ equity $ 155,879 $ 28,272